4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001193125-26-122267
Options or other derivatives
- Chief Medical Officer acquired 68,499 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Patel Naimish · Chief Medical Officer
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-03-20 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +38,499 | 38,499 | D |
| 2026-03-20 | Grant or award : show line 2 in the form Restricted Stock Units | +30,000 | 30,000 | D |
Loading xslF345X06/ownership.xml…